The Journal of Psychedelic Psychiatry was founded with the intent to collect and distribute high-quality research that utilizes psychedelics in the treatment of depression and anxiety with psychedelics in the USA. In the continually evolving world of mental health treatment, psychedelics have shown renewed promise in patients who suffer from treatment-resistant depression, substance use disorders, PTSD, and numerous other conditions. It is the belief of this Journal that psychedelics have the potential to revolutionize the management of psychiatric diseases, drastically altering the current state of the mental health system. Therefore the mission of this Journal is to be a platform through which mental health professionals can find the most up-to-date and critical analysis of the prevailing trends in Psychedelic Psychiatry to educate and inform providers in this ever-changing landscape. 

​